US Stock MarketDetailed Quotes

EVOK Evoke Pharma

Watchlist
  • 0.4510
  • -0.0189-4.02%
Close May 21 16:00 ET
  • 0.4510
  • 0.00000.00%
Post 16:01 ET
3.88MMarket Cap-246P/E (TTM)

Evoke Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
114.15%1.74M
106.51%5.18M
110.45%1.68M
87.82%1.56M
144.99%1.13M
93.70%810.41K
55.04%2.51M
120.86%796.37K
-10.57%832.1K
95.15%461.8K
Operating revenue
114.15%1.74M
106.51%5.18M
110.45%1.68M
87.82%1.56M
144.99%1.13M
93.70%810.41K
55.04%2.51M
120.86%796.37K
-10.57%832.1K
95.15%461.8K
Cost of revenue
82.90%92.53K
-45.50%201.88K
-68.95%59.02K
-61.12%34.91K
-15.37%57.36K
122.28%50.59K
12.88%370.39K
39.07%190.08K
53.63%89.78K
-0.70%67.77K
Gross profit
116.23%1.64M
132.84%4.98M
166.70%1.62M
105.83%1.53M
172.58%1.07M
92.06%759.82K
65.76%2.14M
170.79%606.29K
-14.87%742.33K
134.00%394.02K
Operating expense
7.86%3.14M
25.04%12.41M
51.33%3.5M
17.95%3.13M
14.03%2.86M
19.13%2.91M
5.11%9.92M
30.76%2.32M
-2.28%2.65M
7.24%2.51M
Selling and administrative expenses
10.24%3.14M
27.06%12.23M
52.14%3.48M
19.77%3.13M
19.48%2.77M
18.41%2.85M
8.73%9.62M
31.88%2.29M
-0.78%2.61M
8.08%2.32M
Research and development costs
-93.07%4.65K
-39.52%181.91K
-17.08%22.56K
--0
-51.77%92.36K
60.58%66.99K
-49.06%300.79K
-23.84%27.21K
-50.56%40.39K
-1.92%191.48K
Operating profit
30.34%-1.5M
4.56%-7.43M
-10.42%-1.89M
16.16%-1.6M
15.54%-1.78M
-5.07%-2.16M
4.48%-7.79M
-10.50%-1.71M
-3.67%-1.91M
2.60%-2.11M
Net non-operating interest income expense
10.64%-78.6K
17.49%-361.4K
-6.47%-99.48K
10.70%-90.47K
30.85%-83.49K
28.19%-87.96K
10.87%-437.99K
25.25%-93.44K
18.69%-101.31K
0.74%-120.75K
Non-operating interest income
30.36%46.06K
123.52%138.6K
-18.55%26.54K
43.88%35.56K
952.79%41.16K
4,344.15%35.33K
619.76%62.01K
3,098.04%32.59K
1,639.20%24.71K
29.86%3.91K
Non-operating interest expense
1.11%124.66K
0.00%500K
0.00%126.03K
0.00%126.03K
0.00%124.66K
0.00%123.29K
-0.01%500K
0.00%126.03K
0.00%126.03K
0.00%124.66K
Other net income (expense)
Income before tax
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
3.68%-8.22M
-7.82%-1.8M
-2.26%-2.01M
2.50%-2.23M
Income tax
Net income
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
3.68%-8.22M
-7.82%-1.8M
-2.26%-2.01M
2.50%-2.23M
Net income continuous Operations
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
3.68%-8.22M
-7.82%-1.8M
-2.26%-2.01M
2.50%-2.23M
Minority interest income
Net income attributable to the parent company
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
3.68%-8.22M
-7.82%-1.8M
-2.26%-2.01M
2.50%-2.23M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
3.68%-8.22M
-7.82%-1.8M
-2.26%-2.01M
2.50%-2.23M
Basic earnings per share
74.63%-0.17
11.07%-2.33
-11.32%-0.59
15.00%-0.51
21.13%-0.56
16.25%-0.67
17.61%-2.62
13.11%-0.53
17.81%-0.6
16.47%-0.71
Diluted earnings per share
74.63%-0.17
11.07%-2.33
-11.32%-0.59
15.00%-0.51
21.13%-0.56
16.25%-0.67
17.61%-2.62
13.11%-0.53
17.81%-0.6
16.47%-0.71
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 114.15%1.74M106.51%5.18M110.45%1.68M87.82%1.56M144.99%1.13M93.70%810.41K55.04%2.51M120.86%796.37K-10.57%832.1K95.15%461.8K
Operating revenue 114.15%1.74M106.51%5.18M110.45%1.68M87.82%1.56M144.99%1.13M93.70%810.41K55.04%2.51M120.86%796.37K-10.57%832.1K95.15%461.8K
Cost of revenue 82.90%92.53K-45.50%201.88K-68.95%59.02K-61.12%34.91K-15.37%57.36K122.28%50.59K12.88%370.39K39.07%190.08K53.63%89.78K-0.70%67.77K
Gross profit 116.23%1.64M132.84%4.98M166.70%1.62M105.83%1.53M172.58%1.07M92.06%759.82K65.76%2.14M170.79%606.29K-14.87%742.33K134.00%394.02K
Operating expense 7.86%3.14M25.04%12.41M51.33%3.5M17.95%3.13M14.03%2.86M19.13%2.91M5.11%9.92M30.76%2.32M-2.28%2.65M7.24%2.51M
Selling and administrative expenses 10.24%3.14M27.06%12.23M52.14%3.48M19.77%3.13M19.48%2.77M18.41%2.85M8.73%9.62M31.88%2.29M-0.78%2.61M8.08%2.32M
Research and development costs -93.07%4.65K-39.52%181.91K-17.08%22.56K--0-51.77%92.36K60.58%66.99K-49.06%300.79K-23.84%27.21K-50.56%40.39K-1.92%191.48K
Operating profit 30.34%-1.5M4.56%-7.43M-10.42%-1.89M16.16%-1.6M15.54%-1.78M-5.07%-2.16M4.48%-7.79M-10.50%-1.71M-3.67%-1.91M2.60%-2.11M
Net non-operating interest income expense 10.64%-78.6K17.49%-361.4K-6.47%-99.48K10.70%-90.47K30.85%-83.49K28.19%-87.96K10.87%-437.99K25.25%-93.44K18.69%-101.31K0.74%-120.75K
Non-operating interest income 30.36%46.06K123.52%138.6K-18.55%26.54K43.88%35.56K952.79%41.16K4,344.15%35.33K619.76%62.01K3,098.04%32.59K1,639.20%24.71K29.86%3.91K
Non-operating interest expense 1.11%124.66K0.00%500K0.00%126.03K0.00%126.03K0.00%124.66K0.00%123.29K-0.01%500K0.00%126.03K0.00%126.03K0.00%124.66K
Other net income (expense)
Income before tax 29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M3.68%-8.22M-7.82%-1.8M-2.26%-2.01M2.50%-2.23M
Income tax
Net income 29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M3.68%-8.22M-7.82%-1.8M-2.26%-2.01M2.50%-2.23M
Net income continuous Operations 29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M3.68%-8.22M-7.82%-1.8M-2.26%-2.01M2.50%-2.23M
Minority interest income
Net income attributable to the parent company 29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M3.68%-8.22M-7.82%-1.8M-2.26%-2.01M2.50%-2.23M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M3.68%-8.22M-7.82%-1.8M-2.26%-2.01M2.50%-2.23M
Basic earnings per share 74.63%-0.1711.07%-2.33-11.32%-0.5915.00%-0.5121.13%-0.5616.25%-0.6717.61%-2.6213.11%-0.5317.81%-0.616.47%-0.71
Diluted earnings per share 74.63%-0.1711.07%-2.33-11.32%-0.5915.00%-0.5121.13%-0.5616.25%-0.6717.61%-2.6213.11%-0.5317.81%-0.616.47%-0.71
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg